Authors:
Gaillard, PJ
van der Meide, PH
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Glucocorticoid and type I interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis, NEUROREPORT, 12(10), 2001, pp. 2189-2193
Authors:
Gaillard, PJ
Voorwinden, LH
Nielsen, JL
Ivanov, A
Atsumi, R
Engman, H
Ringbom, C
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelialcells and astrocytes, EUR J PH SC, 12(3), 2001, pp. 215-222
Authors:
van der Sandt, ICJ
Gaillard, PJ
Voorwinden, HH
de Boer, AG
Breimer, DD
Citation: Icj. Van Der Sandt et al., P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier, PHARM RES, 18(5), 2001, pp. 587-592
Authors:
Hofman, P
van Blijswijk, BC
Gaillard, PJ
Vrensen, GFJM
Schlingemann, RO
Citation: P. Hofman et al., Endothelial cell hypertrophy induced by vascular endothelial growth factorin the retina - New insights into the pathogenesis of capillary nonperfusion, ARCH OPHTH, 119(6), 2001, pp. 861-866
Citation: Pj. Gaillard et Ag. De Boer, Relationship between permeability status of the blood-brain barrier and invitro permeability coefficient of a drug, EUR J PH SC, 12(2), 2000, pp. 95-102
Authors:
Gaillard, PJ
van der Sandt, ICJ
Voorwinden, LH
Vu, D
Nielsen, JL
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier, PHARM RES, 17(10), 2000, pp. 1198-1205